STRM.BIO Appoints Independent Director Dawn Bell, PharmD, to its Board
- Wednesday, May 17, 2023, 7:00
- Finance
- Add a comment
BOSTON, May 17, 2023 /PRNewswire/ — STRM.BIO, a pre-clinical, VC-backed biotechnology company that is leveraging extracellular vesicles (EVs) to deliver gene therapies and developing new therapeutics for rare blood diseases, today announced the appointment of Dawn Bell, PharmD, to its…
About the Author
adminasapcorp has written 41611 stories on this site.